KU Leuven has received allegations against one of its researchers regarding possible infringements of scientific integrity. The Commission on Scientific Integrity (CWI) at KU Leuven is looking into the matter. According to a report in De Tijd (paywall), university rector Luc Sels is to call together the Committee on Scientific Integrity following a number of complaints against
This article has a number of surprises and new insights. A Tampa-based regenerative clinic accused of using aggressive and unfair marketing tactics to lure the diseased and desperate into spending thousands of dollars on unproven stem cell therapies laid off a “small number of non-medical” employees earlier this week, a company spokesperson confirmed. While it’s
Daylong symposium at MIT showcases innovative ways of sharing facts and building trust in research results. Source MIT News The amount of trust people place in different professions has ebbed and flowed over the years, though in recent years faith in most categories has plummeted, with Congress and the press among the least-trusted groups, surveys
The first two patients treated with the 3e13 vg/kg dose achieved stable Factor VIII (FVIII) levels demonstrating durability in the normal range through 44 and 37 weeks, respectively– All five patients in the 3e13 vg/kg dose cohort achieved normal range FVIII levels within 5-7 weeks following treatment, with no bleeding events with up to 44 weeks
Offshore tests by a startup seek to lengthen people’s telomeres—and their lives. Source MIT Technology Review It’s said that nothing is certain except death and taxes. But doubt has been cast over the former since the 1970s, when scientists picked at the seams of one of the fundamental mysteries of biology: the molecular reasons we
Polymer-based nanocontainers could improve the delivery of gene therapies, a Johns Hopkins team reported. One of the most popular methods for inserting therapeutic genes into cells to treat disease is to transport them using a virus that has been stripped of its infectious properties. But those noninfectious viruses can still sometimes touch off dangerous immune
The US Food and Drug Administration (FDA) late last month sent an untitled letter, its third of the year, to California-based Chara Biologics for marketing an unapproved stem cell product as a possible treatment for autism and other conditions with few treatment options. FDA says the product appears to be a human cell, tissue, or
To report novel uses of existing medicines for patients with difficult-to-treat infectious diseases The US Food and Drug Administration announced the global launch of CURE ID, an Internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a website, a smartphone
Liveyon Labs Inc. and Liveyon LLC warned that their stem cell products lack required FDA approval and represent a potential risk to the public health The U.S. Food and Drug Administration has warned Liveyon Labs Inc. (Liveyon Labs) and Liveyon LLC, of Yorba Linda, California, and their presidents and chief executive officers, Roya Panah and John
Researchers have found a new way to use math to better treat cancer and prevent its relapse. Using the first mathematical model of its kind, researchers at the University of Waterloo found a way to study the interactions between the immune system and different types of cancer cells. Using their new model, the researchers found
